Is Naloxone still in shortage in 2026? Get the latest update on Narcan availability, pricing, new options, and how to find it in stock near you.
If you've been hearing about Naloxone shortages — or experienced one yourself — you're probably wondering: is it still hard to find in 2026? The answer depends on which formulation you need and where you live.
In this update, we'll cover the current shortage status, why availability issues persist, what Naloxone costs right now, and exactly how to find it near you.
The short answer: it's complicated. The widespread OTC availability of Narcan since September 2023 has significantly improved access to Naloxone nasal spray for the general public. Most major pharmacies now stock Narcan or RiVive on their shelves.
However, certain formulations — particularly injectable Naloxone vials (0.4 mg/mL and 1 mg/mL) used by hospitals and EMS — have continued to experience intermittent supply disruptions. These injectable forms have appeared on the FDA Drug Shortage list on and off since 2018.
Additionally, rural and underserved communities still face access challenges. Pharmacies in these areas may not stock Naloxone consistently, and free distribution programs may be limited.
The opioid crisis continues to drive massive demand for Naloxone. Over 100,000 Americans die from drug overdoses each year, and the push to put Naloxone in the hands of more people — from first responders to family members to bystanders — means demand keeps climbing.
While manufacturers have ramped up production, the shift to OTC distribution created new demand channels (retail shelves, online sales, bulk orders from organizations) that didn't exist before 2023. Supply chains are still adjusting.
Naloxone availability is uneven across the country. Urban pharmacies generally have good stock, while rural areas, tribal communities, and certain regions may struggle. State-funded distribution programs help, but they don't reach everyone.
The injectable vials used in clinical settings face different supply dynamics than OTC nasal sprays. Hospitals need specific concentrations and packaging that aren't interchangeable with retail products. For a deeper look at what's driving these challenges, read why Naloxone is so hard to find in 2026.
Pricing varies by formulation:
Most insurance plans, including Medicaid and Medicare Part D, cover Naloxone with little to no copay. Many free distribution programs exist as well. For detailed savings strategies, see how to save money on Naloxone in 2026.
The Naloxone landscape has expanded significantly in recent years:
These new options mean that even if one specific product is unavailable, there are likely other formulations you can access. See our full breakdown of alternatives to Naloxone.
Here are the most effective strategies:
For a complete guide with more strategies, read how to find Naloxone in stock near you.
While Naloxone availability has improved dramatically since the OTC switch in 2023, challenges remain — especially for injectable formulations and in underserved areas. The good news is that you have more options than ever: multiple formulations, free distribution programs, online ordering, and tools like Medfinder to help you locate it quickly.
If you or someone you know is at risk of opioid overdose, don't wait for a shortage to affect you. Stock up now, know your alternatives, and keep Naloxone accessible. It's a medication that truly saves lives.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
